Paper34273003
Resveratrol effects in oral cancer cells: a comprehensive review.
Almeida TC and 6 others. Med Oncol, 2021. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Resveratrol effects in oral cancer cells: a comprehensive review. Papers, record 34273003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34273003
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents, Phytogenic | Major topic |
| Antioxidants | Major topic |
| Mouth Neoplasms | Major topic |
| Resveratrol | Major topic |
| Cell Survival | |
| Humans | |
| Oxidative Stress |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 001 | cnpq | PubMed | ||
| 001 | cnpq | PubMed | ||
| 001 | capes | PubMed | ||
| 001 | capes | PubMed |
Source PubMed
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33747905 | Resveratrol Mediates the Apoptosis of Triple Negative Breast Cancer Cells by Reducing POLD1 Expression. | Front Oncol | 2021 | https://conductscience.org/library/papers/33747905 | PubMed |
| 2 | 27583211 | Distant metastasis from oral cancer: A review and molecular biologic aspects. | J Int Soc Prev Community Dent | 2016 | https://conductscience.org/library/papers/27583211 | PubMed |
| 3 | 31883986 | NDAT suppresses pro-inflammatory gene expression to enhance resveratrol-induced anti-proliferation in oral cancer cells. | Food Chem Toxicol | 2020 | https://conductscience.org/library/papers/31883986 | PubMed |
| 4 | 32423320 | Combination of Resveratrol and Quercetin Causes Cell Growth Inhibition, DNA Damage, Cell Cycle Arrest, and Apoptosis in Oral Cancer Cells. | Assay Drug Dev Technol | 2020 | https://conductscience.org/library/papers/32423320 | PubMed |
| 5 | 26776043 | Determination of phenolic compounds content and antioxidant activity in skin, pulp, seed, cane and leaf of five native grape cultivars in West Azerbaijan province, Iran. | Food Chem | 2016 | https://conductscience.org/library/papers/26776043 | PubMed |
| 6 | 27742160 | Chemotherapeutic effects of luteolin on radio-sensitivity enhancement and interleukin-6/signal transducer and activator of transcription 3 signaling repression of oral cancer stem cells. | J Formos Med Assoc | 2016 | https://conductscience.org/library/papers/27742160 | PubMed |
| 7 | 32728068 | Zeb1 for RCP-induced oral cancer cell invasion and its suppression by resveratrol. | Exp Mol Med | 2020 | https://conductscience.org/library/papers/32728068 | PubMed |
| 8 | 33686517 | Predictive Value of EGFR-PI3K-AKT-mTOR-Pathway Inhibitor Biomarkers for Head and Neck Squamous Cell Carcinoma: A Systematic Review. | Mol Diagn Ther | 2021 | https://conductscience.org/library/papers/33686517 | PubMed |
| 9 | 26409447 | Resveratrol inhibits oral squamous cell carcinoma through induction of apoptosis and G2/M phase cell cycle arrest. | Tumour Biol | 2016 | https://conductscience.org/library/papers/26409447 | PubMed |
| 10 | 33655717 | Resveratrol-loaded nanomedicines for cancer applications. | Cancer Rep (Hoboken) | 2021 | https://conductscience.org/library/papers/33655717 | PubMed |
| 11 | 33535458 | The Effects of Resveratrol on Prostate Cancer through Targeting the Tumor Microenvironment. | J Xenobiot | 2021 | https://conductscience.org/library/papers/33535458 | PubMed |
| 12 | 33406721 | Impact of Environmental Factors on Stilbene Biosynthesis. | Plants (Basel) | 2021 | https://conductscience.org/library/papers/33406721 | PubMed |
| 13 | 29381815 | Effects of polyphenols on doxorubicin-induced oral keratinocyte cytotoxicity and anticancer potency against oral cancer cells. | J Oral Pathol Med | 2018 | https://conductscience.org/library/papers/29381815 | PubMed |
| 14 | 24243690 | Grape seed extract and resveratrol prevent 4-nitroquinoline 1-oxide induced oral tumorigenesis in mice by modulating AMPK activation and associated biological responses. | Mol Carcinog | 2015 | https://conductscience.org/library/papers/24243690 | PubMed |
| 15 | 19761189 | Phytochemical profiles of different mulberry (Morus sp.) species from China. | J Agric Food Chem | 2009 | https://conductscience.org/library/papers/19761189 | PubMed |
| 16 | 21680702 | Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics. | Cancer Prev Res (Phila) | 2011 | https://conductscience.org/library/papers/21680702 | PubMed |
| 17 | 24384874 | Effects of resveratrol on oral squamous cell carcinoma (OSCC) cells in vitro. | J Cancer Res Clin Oncol | 2014 | https://conductscience.org/library/papers/24384874 | PubMed |
| 18 | 30554657 | Increased expression of tripartite motif (TRIM) like 2 promotes tumoral growth in human oral cancer. | Biochem Biophys Res Commun | 2019 | https://conductscience.org/library/papers/30554657 | PubMed |
| 19 | 23385513 | Oral cancer: Current role of radiotherapy and chemotherapy. | Med Oral Patol Oral Cir Bucal | 2013 | https://conductscience.org/library/papers/23385513 | PubMed |
| 20 | 29148840 | Resveratrol Induces Mitochondrial Apoptosis and Inhibits Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma Cells. | Nutr Cancer | 2018 | https://conductscience.org/library/papers/29148840 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41226384 | Roles of Selected Bioactive Compounds in Inhibiting the Development and Progression of Cancer-A Review. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226384 | PubMed |
| 40888184 | Resveratrol: Sensitising CD44+ Cervical Cancer Cells to Carboplatin and Mitigating Metastasis. | Cancer Med | 2025 | https://conductscience.org/library/papers/40888184 | PubMed |
| 40653555 | Resveratrol in oral cancer: a systematic review of preclinical studies on its anticancer mechanisms and therapeutic potential. | Med Oncol | 2025 | https://conductscience.org/library/papers/40653555 | PubMed |
| 39062744 | Identification and Comprehensive Analysis of circRNA-miRNA-mRNA Regulatory Networks in A2780 Cells Treated with Resveratrol. | Genes (Basel) | 2024 | https://conductscience.org/library/papers/39062744 | PubMed |
| 38575921 | A systematic review and meta-analysis of the impact of resveratrol on oral cancer: potential therapeutic implications. | BMC Oral Health | 2024 | https://conductscience.org/library/papers/38575921 | PubMed |
| 37859687 | Exploring the potential of dietary factors and plant extracts as chemopreventive agents in oral squamous cell carcinoma treatment. | Front Oral Health | 2023 | https://conductscience.org/library/papers/37859687 | PubMed |
| 36829966 | Melanoma Cellular Signaling Transduction Pathways Targeted by Polyphenols Action Mechanisms. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/36829966 | PubMed |
| 35387267 | Research Progress on Natural Products' Therapeutic Effects on Atrial Fibrillation by Regulating Ion Channels. | Cardiovasc Ther | 2022 | https://conductscience.org/library/papers/35387267 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34273003
GET https://conductscience.org/api/papers/v1/34273003/references?page=2